PPAT and neuroendocrine carcinoma: The observation that PPAT expression was significantly associated with poor prognosis for neuroendocrine cancer prompted us to investigate whether such expression is also related to the outcome of SCLC, which is thought to be a high-grade neuroendocrine cancer23.